Status:
COMPLETED
Establishing Baseline Sysmex UF-5000 Flow Cytometer Results in Healthy Men
Lead Sponsor:
Indiana University
Conditions:
Urethritis
Healthy Men Age 18-50 With no Urethral Symptoms
Eligibility:
MALE
18-50 years
Phase:
NA
Brief Summary
Acute urethritis (inflammation of the male urethra) affects millions of men in the United States each year. Effective management of STIs is complicated by asymptomatic infections, as men often delay ...
Detailed Description
Acute urethritis (i.e., inflammation of the male urethra) affects millions of men within the United States annually. In young sexually active men, urethritis is most commonly caused by the sexually tr...
Eligibility Criteria
Inclusion
- Men aged 18 to 50.
- No urethral symptoms (discharge, dysuria)
Exclusion
- History of genital surgery or known urethral abnormalities
- Testing positive for gonorrhea and chlamydia
- Diagnosis of a sexually transmitted infection within the last year.
- Not available to collect a urine specimen in the morning 3x/week for 2 weeks
Key Trial Info
Start Date :
April 9 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 7 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06951009
Start Date
April 9 2025
End Date
May 7 2025
Last Update
July 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University
Indianapolis, Indiana, United States, 46202